NNVC - this is my favorite bird flu stock from the basket. Probably the most frequent question I get on NNVC is why would anyone buy a 20 cent stock? "The stock is 20 cents for a reason, right?"
Actually, those questions came a week ago when the stocks was 9 cents, now it's 20 X 22 cents. That's one reason.
Additionally, here are some serious resumes involved with the Management and Advisor Board at NNVC, which indicates to me that NNVC has something significant in their science.
Executive Team
Eugene Seymour, MD, MPH, CEO
Treatment and Diagnosis of HIV has been Gene's passion for 25 years.
Anil R. Diwan, PhD, President
Inventor of TheraCour technology that enables NanoViricides drugs.
Krishna Menon, VMD, PhD, CRO
Expert in Pre-clinical and Clinical Studies of Billion-dollar drugs.
Randall Barton, PhD, CSO
Expert in Receptor-based Drug Development.
Here's a link to a more complete description of the Management's credentials and from where you learn a lot more about the products and technology of the company:
nanoviricides.com
The leverage of a 20 cent stock played against the coming bird flu mania enormous. That's why we're here.
A |
